Found operates multiple plan tiers (compounded, branded, non-GLP-1) that may be billed separately from lab fees — confirm exactly which charges are active before you cancel, and line up your next step first.
If you're switching, Luma Health's semaglutide ($197/month) and tirzepatide ($297/month) include a medical evaluation to plan continuity.
Leaving Found cleanly starts with understanding exactly what you're currently being billed for, since its multi-tier plan structure means membership, medication, and lab costs aren't always a single combined charge.
Step 1: Identify Every Active Charge
Log into your account and review your current plan tier (compounded, branded, or non-GLP-1), your membership billing cycle, and whether any lab testing was billed separately. Found's structure means these can be distinct line items rather than one bundled subscription, so confirm what's actually active before assuming a single cancellation covers everything.
Step 2: Line Up Continuity Before You Cancel
If you're switching providers rather than stopping treatment, start your new provider's medical evaluation while you still have 2-3 weeks of medication remaining. Share your current medication, dose, duration, and any side effects with your new provider so they can continue your treatment appropriately rather than restarting titration unnecessarily.
Before cancelling, confirm your exact renewal date and how far ahead you need to cancel to avoid being charged for the next cycle. Timing your cancellation just before renewal, rather than right after, avoids paying for a period you won't use.
Step 3: Cancel Through the Appropriate Channel
Cancellation is typically available through account settings, or by contacting support directly if self-service isn't available for your specific plan tier. Be explicit about which plan and any add-on services (like lab coordination) you're cancelling, given how Found's billing can be segmented.
Step 4: Confirm and Monitor
Save written confirmation of your cancellation. Check your bank or card statement for two to three billing cycles afterward to confirm all relevant charges have actually stopped, since a multi-tier structure raises the odds that one component gets missed.
Your Exit Checklist
- Confirm your specific plan tier and any separately billed services
- Start your new provider's intake if you're switching, not stopping
- Note your current dose and treatment history to share
- Save written confirmation of every cancelled component
- Check statements for 2-3 billing cycles to confirm charges stopped
- Dispute any charges that continue despite confirmed cancellation
One plan.
One simple price.
Luma Health's compounded semaglutide ($197/month) and tirzepatide ($297/month) include your medical evaluation, provider visits, and shipping — no separate tiers to track.
Get Started → Or start your free health assessmentFrequently Asked Questions
It can, depending on your specific plan tier. Confirm exactly which charges are active on your account before assuming a single cancellation covers everything.
Start your new provider's medical evaluation while you still have 2-3 weeks of medication remaining, so your new prescription is approved and shipping before your current supply runs out.
Just before your next renewal date, to avoid being charged for a billing cycle you won't use. Confirm your exact renewal date in your account settings.
Your current medication and dose, how long you've been taking it, and any side effects — this helps a new provider continue your treatment without unnecessary retitration.
Save your cancellation confirmation and check your statement for two to three billing cycles afterward, since Found's multi-tier billing raises the chance one component gets missed.
Generally yes, since a single all-inclusive price removes the need to track separate membership, medication, and lab charges across multiple billing cycles.
References
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24(8):1553-1564. PubMed 35441470
- U.S. Food and Drug Administration. Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide). FDA.gov. 2025. FDA Drug Approvals Database